title: Oncology in 2012: from personalized medicine to precision medicine.
authors.forename: J F
authors.initials: JF
authors.lastname: Morere
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000235:genetics*; D000813:Anilides / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D000077547:Crizotinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics*; D008495:Medical Oncology / Q000639:trends; D058990:Molecular Targeted Therapy; D057285:Precision Medicine; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; D011518:Proto-Oncogene Proteins; D011720:Pyrazoles; D011725:Pyridines; C558660:cabozantinib; D000077547:Crizotinib; D011505:Protein-Tyrosine Kinases; C062333:ROS1 protein, human